Alvotech (ALVO) Payables (2020 - 2026)
Alvotech's (ALVO) quarterly Payables came in at $171.8 million in Q2 2026, up 16.67% on a YoY basis from $147.3 million in Q2 2025, and up 43.65% quarter-over-quarter from $119.6 million in Q1 2026.
Analysis
Alvotech (ALVO) Payables (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Payables for 7 consecutive years, with $171.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables rose 16.67% year-over-year to $171.8 million; the trailing twelve-month figure through Jun 2026 stood at $171.8 million (up 16.67% YoY), and the FY2025 full-year result was $180.1 million, down 35.06% from the prior year.
- Payables rose to $171.8 million in Q2 2026 per ALVO's latest filing, from $119.6 million in the prior quarter.
- Across five years, Payables topped out at $601.1 million in Q4 2023 and bottomed at $66.4 million in Q2 2023.
- Historically, Payables has averaged $264.1 million across 5 years, with a median of $251.2 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Payables surged 1395.92% in 2022, then slumped 72.59% in 2023.
- Over 5 years, Payables stood at $429.4 million in 2022, then surged by 39.98% to $601.1 million in 2023, then sank by 53.86% to $277.3 million in 2024, then sank by 35.06% to $180.1 million in 2025, then decreased by 4.59% to $171.8 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $171.8 million, $119.6 million, and $180.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 2.72 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.73 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 449.39 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 721.21 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 593.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 171.84 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 73.83 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 251.37 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 5.52 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 731,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171.84 Mn |
| Mar 31, 2026 | 119.63 Mn |
| Dec 31, 2025 | 180.12 Mn |
| Sep 30, 2025 | 301.85 Mn |
| Jun 30, 2025 | 147.29 Mn |
| Mar 31, 2025 | 278.11 Mn |
| Dec 31, 2024 | 277.35 Mn |
| Sep 30, 2024 | 240.08 Mn |
| Jun 30, 2024 | 260.24 Mn |
| Mar 31, 2024 | 381.15 Mn |
| Dec 31, 2023 | 601.12 Mn |
| Jun 30, 2023 | 66.39 Mn |
| Dec 31, 2022 | 429.42 Mn |
| Jun 30, 2022 | 242.20 Mn |
| Dec 31, 2021 | 28.71 Mn |
| Dec 31, 2020 | 546.65 Mn |